These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33469668)

  • 1. Biological Effective Dose as a Predictor of Hypopituitarism After Single-Fraction Pituitary Adenoma Radiosurgery: Dosimetric Analysis and Cohort Study of Patients Treated Using Contemporary Techniques.
    Graffeo CS; Perry A; Link MJ; Brown PD; Young WF; Pollock BE
    Neurosurgery; 2021 Mar; 88(4):E330-E335. PubMed ID: 33469668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypopituitarism After Single-Fraction Pituitary Adenoma Radiosurgery: Dosimetric Analysis Based on Patients Treated Using Contemporary Techniques.
    Graffeo CS; Link MJ; Brown PD; Young WF; Pollock BE
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):618-623. PubMed ID: 29678524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose to neuroanatomical structures surrounding pituitary adenomas and the effect of stereotactic radiosurgery on neuroendocrine function: an international multicenter study.
    Pomeraniec IJ; Xu Z; Lee CC; Yang HC; Chytka T; Liscak R; Martinez-Alvarez R; Martinez-Moreno N; Attuati L; Picozzi P; Kondziolka D; Mureb M; Bernstein K; Mathieu D; Maillet M; Ogino A; Long H; Kano H; Lunsford LD; Zacharia BE; Mau C; Tuanquin LC; Cifarelli C; Arsanious D; Hack J; Warnick RE; Strickland BA; Zada G; Chang EL; Speckter H; Patel S; Ding D; Sheehan D; Sheehan K; Kvint S; Buch LY; Haber AR; Shteinhart J; Vance ML; Sheehan JP
    J Neurosurg; 2022 Mar; 136(3):813-821. PubMed ID: 34560630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Insulin-Like Growth Factor Index and Biologically Effective Dose on Outcomes After Stereotactic Radiosurgery for Acromegaly: Cohort Study.
    Graffeo CS; Donegan D; Erickson D; Brown PD; Perry A; Link MJ; Young WF; Pollock BE
    Neurosurgery; 2020 Sep; 87(3):538-546. PubMed ID: 32267504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term radiographic and endocrinological outcomes of stereotactic radiosurgery for recurrent or residual nonfunctioning pituitary adenomas.
    Shaaban A; Dumot C; Mantziaris G; Dayawansa S; Peker S; Samanci Y; Nabeel AM; Reda WA; Tawadros SR; Abdel Karim K; El-Shehaby AMN; Emad Eldin RM; Ragab Abdelsalam A; Liscak R; May J; Mashiach E; De Nigris Vasconcellos F; Bernstein K; Kondziolka D; Speckter H; Mota R; Brito A; Bindal SK; Niranjan A; Lunsford LD; Benjamin CG; Almeida T; Mao JZ; Mathieu D; Tourigny JN; Tripathi M; Palmer JD; Matsui J; Crooks J; Wegner RE; Shepard MJ; Sheehan JP
    J Neurosurg; 2024 Sep; 141(3):773-780. PubMed ID: 38518285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypopituitarism after stereotactic radiosurgery for pituitary adenomas.
    Xu Z; Lee Vance M; Schlesinger D; Sheehan JP
    Neurosurgery; 2013 Apr; 72(4):630-7; 636-7. PubMed ID: 23277375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of distance from target on hypopituitarism after stereotactic radiosurgery for pituitary adenomas.
    Ironside N; Snyder H; Xu Z; Schlesinger D; Chen CJ; Vance ML; Hong GK; Jane JA; Sheehan JP
    J Neurooncol; 2022 May; 158(1):41-50. PubMed ID: 35461378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with endocrine deficits after stereotactic radiosurgery of pituitary adenomas.
    Leenstra JL; Tanaka S; Kline RW; Brown PD; Link MJ; Nippoldt TB; Young WF; Pollock BE
    Neurosurgery; 2010 Jul; 67(1):27-32; discussion 32-3. PubMed ID: 20559089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of biological effective dose for prediction of endocrine remission in acromegaly patients treated with stereotactic radiosurgery.
    Dumot C; Schlesinger D; Mantziaris G; Dayawansa S; Xu Z; Sheehan JP
    Pituitary; 2023 Feb; 26(1):124-131. PubMed ID: 36471108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of fractionated radiotherapy and stereotactic radiosurgery for pituitary adenomas: long-term results of 125 consecutive patients treated in a single institution.
    Kong DS; Lee JI; Lim DH; Kim KW; Shin HJ; Nam DH; Park K; Kim JH
    Cancer; 2007 Aug; 110(4):854-60. PubMed ID: 17599761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypopituitarism after Gamma Knife surgery for postoperative nonfunctioning pituitary adenoma.
    Oh JW; Sung KS; Moon JH; Kim EH; Chang WS; Jung HH; Chang JW; Park YG; Kim SH; Chang JH
    J Neurosurg; 2018 Dec; 129(Suppl1):47-54. PubMed ID: 30544293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic Radiosurgery for Residual and Recurrent Nonfunctioning Pituitary Adenomas: A Contemporary Case Series of GammaKnife and CyberKnife Radiosurgery.
    Tucker D; Penn M; Brunswick A; Uttarwar V; Gogia A; Marietta M; Yu C; Carmichael J; Chang E; Zada G
    World Neurosurg; 2020 Nov; 143():e60-e69. PubMed ID: 32603864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Neuroanatomic Structural Distances on Pituitary Function After Stereotactic Radiosurgery: A Multicenter Study.
    Ironside N; Chen CJ; Xu Z; Schlesinger D; Lee Vance M; Hong GK; Jane JA; Patel S; Bindal SK; Niranjan A; Lunsford LD; Liscak R; Chytka T; Jezkova J; Saifi O; Trifiletti DM; Berger A; Alzate J; Bernstein K; Kondziolka D; Speckter H; Hernandez W; Lazo E; Peker S; Samanci Y; Zacharia BE; Mau C; Wegner RE; Shepard MJ; Mathieu D; Maillet M; Sheehan JP
    Neurosurgery; 2023 May; 92(5):1035-1042. PubMed ID: 36700741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of higher dose stereotactic radiosurgery for functional pituitary adenomas: a preliminary report.
    Grant RA; Whicker M; Lleva R; Knisely JP; Inzucchi SE; Chiang VL
    World Neurosurg; 2014; 82(1-2):195-201. PubMed ID: 23385448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypopituitarism after gamma knife radiosurgery for pituitary adenoma.
    Zibar Tomšić K; Dušek T; Kraljević I; Heinrich Z; Solak M; Vučinović A; Ozretić D; Mihailović Marasanov S; Hršak H; Kaštelan D
    Endocr Res; 2017 Nov; 42(4):318-324. PubMed ID: 28537768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic radiosurgery for non-functioning pituitary adenomas: meta-analysis and International Stereotactic Radiosurgery Society practice opinion.
    Kotecha R; Sahgal A; Rubens M; De Salles A; Fariselli L; Pollock BE; Levivier M; Ma L; Paddick I; Regis J; Sheehan J; Yomo S; Suh JH
    Neuro Oncol; 2020 Mar; 22(3):318-332. PubMed ID: 31790121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic radiosurgery for nonfunctioning pituitary tumor: A multicenter study of new pituitary hormone deficiency.
    Dumot C; Mantziaris G; Dayawansa S; Peker S; Samanci Y; Nabeel AM; Reda WA; Tawadros SR; Abdelkarim K; El-Shehaby AMN; Emad RM; Abdelsalam AR; Liscak R; May J; Mashiach E; De Nigris Vasconcellos F; Bernstein K; Kondziolka D; Speckter H; Mota R; Brito A; Bindal SK; Niranjan A; Lunsford DL; Benjamin CG; Abrantes de Lacerda Almeida T; Mao J; Mathieu D; Tourigny JN; Tripathi M; Palmer JD; Matsui J; Crooks J; Wegner RE; Shepard MJ; Vance ML; Sheehan JP
    Neuro Oncol; 2024 Apr; 26(4):715-723. PubMed ID: 38095431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic Radiosurgery for Acromegaly: An International Multicenter Retrospective Cohort Study.
    Ding D; Mehta GU; Patibandla MR; Lee CC; Liscak R; Kano H; Pai FY; Kosak M; Sisterson ND; Martinez-Alvarez R; Martinez-Moreno N; Mathieu D; Grills IS; Blas K; Lee K; Cifarelli CP; Katsevman GA; Lee JYK; McShane B; Kondziolka D; Lunsford LD; Vance ML; Sheehan JP
    Neurosurgery; 2019 Mar; 84(3):717-725. PubMed ID: 29757421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma Knife radiosurgery for acromegaly: Evaluating the role of the biological effective dose associated with endocrine remission in a series of 42 consecutive cases.
    Balossier A; Tuleasca C; Cortet-Rudelli C; Soto-Ares G; Levivier M; Assaker R; Reyns N
    Clin Endocrinol (Oxf); 2021 Mar; 94(3):424-433. PubMed ID: 32984972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target delineation and optimal radiosurgical dose for pituitary tumors.
    Minniti G; Osti MF; Niyazi M
    Radiat Oncol; 2016 Oct; 11(1):135. PubMed ID: 27729088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.